Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Learn more

Follow-up after treatment

Follow-up care visualization post-treatment for Neuroendocrine Tumors (NET).

Follow-up after treatment

Many diagnostic tests initially used to detect NETs are also used to closely monitor them and check if treatments are working or if the disease is progressing. Most patients will inevitably experience progression during their NET journey1, which means the tumor will grow or new tumors will appear in other body parts. It is essential to inform your doctor if you notice any changes or experience any new symptoms because they might mean the disease is progressing. Routine follow-up tests can help your doctor detect any changes, even without symptoms.

Scans help doctors to identify progression, since they can measure the size of tumors and determine whether or how much the tumors have grown compared to the initial scans. Some scans can detect if new tumors have developed in other parts of the body. Laboratory tests, including urine and blood tests, may also be used with scans to measure hormone levels associated with tumor growth.

Results from these periodic follow-up tests will help your doctors determine if your medication needs to be adjusted or if you should try alternative treatment options.

Back to overview Subsequent treatment options
You’re now leaving the website myNETjourney.com
This link is provided for information purposes only. Please be aware that, if you click on it, you will leave myNETjourney.com website. The link will take you to a website owned and operated by an independent party over which ITM Oncologics GmbH has no control or influence (“third-party website”).
ITM Oncologics GmbH makes no representation that information on the third-party website is appropriate or available for use or access in locations outside the country for which the third-party website is intended. Therefore, ITM Oncologics GmbH declines any responsibility for third-party information. ITM Oncologics GmbH makes no representation regarding the data usage policies of the third party website and declines any responsibility for the use of personal data by the operator of the third-party website. Please ensure that you belong to the intended audience of the content provided on third-party website and that your access to it complies with the applicable laws and regulations.
 
Do you really want to leave the myNETjourney.com website?
Welcome to myNETjourney.com
In order to provide you with information tailored to your needs, we kindly ask you to select one of the following: